Last reviewed · How we verify
NCT07520994
Efficacy of Devices in Maintaining Oral Health and Managing Periodontal and Interproximal Tissues: a RCT
NA trial testing Group 1: use of the rubber interdental brush (picks) at baseline for 3 months in Gingivitis in 40 participants. Participants enrolled and being followed up; not accepting new ones.
1 November 2025
Quick facts
| Lead sponsor | University of Roma La Sapienza |
|---|---|
| Phase | NA |
| Status | Active, enrolled |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 40 |
| Start date | 1 September 2023 |
| Primary completion | 1 November 2025 |
| Estimated completion | 30 April 2026 |
| Sites | 1 location across Italy |
Drugs / interventions tested
- Group 1: use of the rubber interdental brush (picks) at baseline for 3 months
- Group 2: use of the traditional bristle interdental brush at baseline for 3 months
Conditions studied
- Gingivitis — all drugs for Gingivitis →
- Gum Disease — all drugs for Gum Disease →
- Oral Health — all drugs for Oral Health →
Sponsor
University of Roma La Sapienza
Who can join
Adults 18 to 50, any sex, with Gingivitis or Gum Disease. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of the study was to assess the acceptability of the assisted individual and compliance with home use, as well as their clinical impact on the plaque index (PI) and bleeding on probing (BOP), with monthly reassessments allowing for continuous monitoring of all parameters.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07520994
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Gingivitis
Currently open trials in the same condition.
- NCT07501455 — Comparison of the Effects of Oral Hygiene Regimens on Clinical, Immunomodulatory, and Microbial Outcomes and Oral Tolera · NA · recruiting
- NCT07499596 — Effect of Morus Nigra Mouthwash on Gingivitis Treatment · NA · recruiting
- NCT07270705 — Assessment of the Efficacy and Safety of OROXID® Oral Solution in Patients With Gingivitis · NA · recruiting
- NCT07164989 — Motivational Interviewing to Improve Oral Hygiene in Adolescent Orthodontic Patients · NA · active not recruiting
- NCT07530978 — ORAL HYGIENE, PERIODONTAL STATUS AND QUALITY OF LIFE · recruiting
Other University of Roma La Sapienza trials
Trials by the same sponsor.
- NCT07485023 — Oral Versus Intravenous Iron for Anemia Diagnosed After 34 Weeks of Gestation · NA · not yet recruiting
- NCT07305519 — The Combined Effect of Magnesium, Palmitoylethanolamide, High-Molecular-weight Hyaluronic Acid, Vitamin B6, and Vitamin · NA · not yet recruiting
- NCT07520968 — ABX Versus CHX in NSPT: a RCT · NA · active not recruiting
- NCT07109596 — Integration of Clinical, Biological and Psycho-social Variables for a Gender-sensitive Frailty Prediction · recruiting
- NCT07490574 — Trial of Underwater Versus Gas-Insufflation Colorectal Endoscopic Submucosal DisseEtion · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07520994 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Roma La Sapienza
- Last refreshed: 9 April 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07520994.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing